Mechanistically, the MAPK14/p53/Slurp1 signaling pathway may play a critical role in lobeline‐induced regulation of TAMs polarization and the subsequent reduction of CRC tumor load, providing a mechanistic rationale for employing lobelia as a therapeutic agent against CRC. The gene discussed is MAPK14; the disease is neoplasm.